From early August to late September 2026, the NHS has experienced record operational pressures alongside major regulatory milestones and continued expansion of community‑based care. For practice managers, this period brings significant implications for workforce governance, service planning, and compliance.
1. Record Summer Pressures Across Urgent and Emergency Care
NHS England confirmed that June–August 2026 was the busiest summer in NHS history, with 7,268,445 A&E attendances. Despite this unprecedented demand, four‑hour performance improved compared with previous summers.
Key operational points
- Heatwaves drove surges in dehydration, respiratory exacerbations, and frailty‑related presentations.
- Ambulance incidents and 999 calls reached historic highs.
- Elective performance improved modestly, though cancer pathways continued to miss targets.
- Staff‑support measures were implemented nationally during extreme heat.
Implications for practice managers
- Higher acuity presentations in general practice.
- Increased pressure on same‑day/urgent appointment capacity.
- Need to incorporate summer resilience planning into annual operational cycles.
- More A&E visits mean more administrative work for surgeries, a fact often overlooked in national reporting.
2. Major Expansion of Mental Health Services
On 5–6 August, the Government announced a £343 million transformation of mental health crisis care.
Key components
- 100 new community mental health centres offering walk‑in support without referral.
- 59 dedicated mental health emergency departments to divert crisis patients from A&E.
- First centres open autumn 2026, with further rollout from March 2027.
Implications
- New local pathways will require updated governance frameworks.
- Potential reduction in mental‑health‑related GP attendances.
- Integration with PCN mental health practitioners will be essential.
3. Physician Associates: Mandatory GMC Registration Deadline Approaches
The most significant workforce development this period is the end of the GMC’s two‑year transition period for Physician Associates (PAs) and Anaesthesia Associates (AAs).
Key facts
- Deadline: 13 December 2026.
- After this date, it becomes a criminal offence to use the titles Physician Associate or Anaesthesia Associate without GMC registration.
- Applications submitted after 14 September may not be processed in time.
- Employers must check registration status via the GMC online register.
Governance implications
- Update staff files, job descriptions, and supervision policies.
- Ensure MDT structures reflect protected titles and GMC oversight.
- Prepare contingency plans if any PA/AA does not register in time.
CQC relevance
- CQC inspectors will expect evidence of GMC registration for PAs/AAs from December.
- Non‑compliance may trigger workforce safety concerns.
4. Ghost Patient Removals and List‑Cleansing Impact
NHS England’s accelerated “ghost patient” removals have become a significant operational and financial issue for practices during 2025–2026. The shortened three‑month response window for list‑validation letters has led to over 480,000 patients being deducted nationally, with deprived areas disproportionately affected. GP leaders warn that vulnerable patients — including those with long‑term conditions, limited mobility, or unstable housing — are being removed in error, requiring urgent re‑registration, and creating gaps in continuity of care.
Primary care is increasingly charged with correcting registration details that NHS England has monitored poorly, and while appropriate list‑cleansing is necessary, the scale and speed of recent deductions risk undermining practice viability. Several LMCs have reported unexpected funding losses, with some areas losing tens of thousands of patients in months, creating substantial reductions in core income, and raising concerns about sustainability.
5. CQC Inspection & Regulatory Updates (2026)
Although CQC has not issued a new GP‑specific inspection framework during August–September, several national regulatory changes will directly influence how practices are inspected.
Key updates
- CQC is on track to complete 9,000 assessments by September 2026, increasing inspection frequency across all sectors.
- New risk‑based prioritisation rules mean services with older ratings, emerging risks, or no previous assessments are inspected first.
- A new proportionate assessment model is being used for low‑risk services, focusing more on people’s experiences and targeted evidence.
- CQC is redesigning its entire regulatory process (2026–2028), including digital tools and a new provider portal.
- Registration rules tightened in February 2026: incomplete applications are now rejected immediately.
Implications for GP practices
- Expect more frequent contact and risk‑based inspections.
- Greater scrutiny of workforce compliance, including PA/AA GMC registration.
- Increased focus on shared‑care governance with pharmacies, especially under Pharmacy First.
- Practices should ensure governance documentation is up‑to‑date ahead of winter inspections.
6. Pharmacy Treatment Expansion (Autumn 2026)
Pharmacy‑based care continues to expand rapidly, with significant implications for general practice.
A. Existing Pharmacy First Clinical Pathways
Pharmacists already treat seven common conditions:
- Earache
- Impetigo
- Infected insect bites
- Shingles
- Sinusitis
- Sore throat
- Uncomplicated UTIs (women)
These pathways require structured clinical assessment and record‑keeping, now subject to national audit.
B. New Autumn 2026 Expansion
From autumn, participating pharmacies will also treat:
- Migraines
- Acne
- Scabies
- Ear infections
- Selected minor skin conditions.
C. Independent Prescribing in Pharmacies (from 1 October 2026)
Pharmacist independent prescribers will be able to prescribe within NHS Advanced Services, including:
- Pharmacy First
- Pharmacy Contraception Service
This is subject to ICB authorisation and strict governance requirements.
D. Implications for GP Practices
- Clear documentation and communication pathways are essential.
- Reliable coding of pharmacy‑initiated treatments is required for continuity of care.
- Robust safety‑netting advice must be maintained.
- As clinical responsibility in pharmacy grows, CQC will expect evidence of safe shared‑care governance.
7. What This Period Means for Practice Managers
Governance
- Update policies for PA/AA regulation and GMC compliance.
- Prepare for CQC scrutiny of workforce registration and supervision.
- Review digital triage guidance in light of research showing over‑referral risks.
Workforce
- Monitor morale and retention as GMC Order 2026 reforms progress.
- Adjust MDT skill mix considering pharmacy expansion and PA regulation.
Operational Planning
- Record summer pressures indicate that summer resilience is now as critical as winter planning.
- Prevention initiatives require robust recall systems and data‑sharing pathways.
Patient Safety
- Ensure safety‑netting for pharmacy‑managed conditions.
- Maintain clear escalation pathways for mental health crises.
Conclusion
August–September 2026 has been defined by record demand, major regulatory change, and a continued shift toward community‑based prevention and treatment. For practice managers, the challenge is to integrate these developments into local governance frameworks while maintaining safe, accessible services ahead of what is likely to be another difficult winter.
References
- NHS England – Urgent and Emergency Care Daily Situation Reports, Summer 2026
- NHS England – Mental Health Crisis Care Expansion Announcement, 5–6 August 2026
- General Medical Council – PA/AA Registration Transition Period Guidance, 2026
- General Medical Council – GMC Order 2026 Regulatory Reform Overview
- NHS England – List Maintenance and Patient Deduction Data, 2025–2026
- Local Medical Committees – Reports on Ghost Patient Removals and Funding Impact, 2026
- Care Quality Commission – Inspection Prioritisation Criteria Update, May 2026
- Care Quality Commission – Regulatory Process Redesign Programme, 2026–2028
- NHS England – Pharmacy First Clinical Pathways and Autumn 2026 Expansion
- NHS England – Pharmacist Independent Prescribing Regulations, October 2026
0 Comments